Internal Medicine, Gastroenterology · Live Oak, TX
NPI
1699765461
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
12850 Toepperwein Rd
Live Oak, TX, 78233
Phone (210) 614-1234
Groups this clinician bills Medicare through
Medicare paid, 2024
$173K
1,467 services
Medicare patients, 2024
929
Average age 73
Drug cost, 2024
$1.9M
2,771 prescriptions
Company payments, 2025
$1,682
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hays L Arnold III was code 45385 (colonoscopy - lesion removal), 325 times for 323 patients. In total Hays L Arnold III billed 1,467 services in 44 codes, and Medicare paid $173K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45385 Colonoscopy - Lesion Removal | Facility | 325 | 323 | $198.02 | $64K |
| 99214 Office E&M - Established | Office | 193 | 157 | $87.27 | $17K |
| 43239 Upper GI Endoscopy | Facility | 175 | 171 | $70.53 | $12K |
| 99213 Office E&M - Established | Office | 152 | 134 | $59.35 | $9,022 |
| 99204 Office E&M - New | Office | 135 | 135 | $110.32 | $15K |
| 99203 Office E&M - New | Office | 59 | 59 | $68.64 | $4,050 |
| 43235 Upper GI Endoscopy | Facility | 57 | 56 | $78.74 | $4,488 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 56 | 56 | $168.57 | $9,440 |
| 43450 Digestive/Gastrointestinal | Facility | 53 | 53 | $29.52 | $1,565 |
| 91065 Test - Miscellaneous | Office | 47 | 44 | $50.22 | $2,360 |
| 46221 Digestive/Gastrointestinal | Office | 38 | 22 | $197.50 | $7,505 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 37 | 37 | $172.34 | $6,377 |
| 45380 Lower GI Endoscopy - Other | Facility | 30 | 30 | $92.95 | $2,788 |
| 45378 Lower GI Endoscopy - Other | Facility | 15 | 15 | $133.41 | $2,001 |
| 91110 Standard X-ray | Office | 14 | 14 | $511.58 | $7,162 |
By year: 2022 $175K for 1,866 services; 2023 $190K for 1,504 services; 2024 $173K for 1,467 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hays L Arnold III prescribed most often to Medicare patients was Pantoprazole Sodium, with 611 prescriptions and refills. In total Hays L Arnold III wrote 2,771 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 611 | 1,682 | 235 | $8,463 |
| Famotidine Generic | 227 | 572 | 75 | $4,964 |
| Omeprazole Generic | 121 | 306 | 40 | $2,001 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 114 | 114 | 110 | $1,851 |
| Rabeprazole Sodium Generic | 93 | 195 | 29 | $9,076 |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 88 | 88 | 86 | $12K |
| Suflave Peg 3350/Sod Sulf,chlr/Pot/Mag | 86 | 86 | 85 | $11K |
| Linzess Linaclotide | 83 | 195 | 32 | $103K |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 72 | 72 | 72 | $12K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 69 | 69 | 68 | $1,049 |
| Creon Lipase/Protease/Amylase | 58 | 92 | 25 | $186K |
| Ursodiol Generic | 51 | 108 | 15 | $7,711 |
| Xifaxan Rifaximin | 48 | 48 | 20 | $111K |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 38 | 38 | 38 | $6,189 |
| Lactated Ringers Ringer's Solution,lactated | 37 | 37 | Under 11 | $884 |
Brand drugs: - claims; generic drugs: 1,908 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hays L Arnold III $1,682 ($1,682 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $585.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 36 | $585 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $175 |
| Echosens North America, Inc. | 1 | $157 |
| Madrigal Pharmaceuticals MDGL | 7 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 6 | $108 |
| Gilead Sciences, Inc. GILD | 5 | $105 |
| Janssen Biotech, Inc. JNJ | 4 | $82.15 |
| Lilly USA, LLC LLY | 4 | $80.16 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 3 | $70.77 |
| Pfizer Inc. PFE | 4 | $64.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.